Blog

Mar 2020

Coronavirus | COVID-19 RACT Now Available

By |2020-03-26T12:29:28+00:00March 20, 2020|Blog, News|0 Comments

Cyntegrity developed a special COVID-19 RACT that guides those involved in clinical trials on specific risks which may arise as a result of COVID-19, and how they can mitigate them. This special RACT is part of the COVID-19 rapid deployment pack for ad-hoc centralized monitoring.

Feb 2020

Indication Focused RBQM for Rare Disease Drug Development

By |2020-02-28T08:30:17+00:00February 28, 2020|Blog|0 Comments

Adaptive and intelligent Risk Based Quality Management (RBQM) is a powerful strategy for rare disease research. One of the main benefits is that RBQM allows for patient-centric trial design that is uniquely tailored to the specific rare disease.

Feb 2020

Healthy Volunteers – Phase 1 RACT Now Available

By |2020-02-17T08:17:26+00:00February 11, 2020|Blog, News|0 Comments

The need for a controlled research environment adds another risk dimension to the Phase 1 study design. The new Healthy Volunteers - Phase 1 RACT serves as a helpful source to ensure maximum subject safety and a reliable outcome.

Dec 2019

Challenges Associated with Clinical Research in Heart Failure

By |2020-02-11T12:57:00+00:00December 19, 2019|Blog|0 Comments

Heart Failure (HF) is a complex clinical syndrome. Our CSO, Dr Johann Proeve, explains the challenges associated with the conduct of clinical studies in the various heart failure stages.

Dec 2019

Quality by Design | ICH E8(R1) General Considerations for Clinical Studies

By |2020-01-15T09:38:50+00:00December 18, 2019|Blog, Free Infographics for Clinical Experts|0 Comments

ICH E8(R1) discourages the old-school “one size fits all” approach, instead the modern day guidance encourages bio-pharma to go beyond the traditional checklists. We've visualized the 2019 guidance "General Considerations for Clinical Studies". Download our free infographic today to be ready for tomorrow.

Jul 2019

A Clinical Research Must-Have: Next Generation Predictive Analytics

By |2019-07-08T11:57:09+00:00July 8, 2019|Blog|0 Comments

Predictive Analytics is seen as the next generation methodology: “growing across most therapy areas in the coming years”. Pharma companies and CROs that embrace next generation analytics will position themselves for immeasurable competitive edge in the industry. 

Upcoming Events

  1. MINDS-ON | Impact COVID-19 on Clinical Trials

    March 30 @ 3:00 pm - 4:30 pm UTC+0
  2. 25th Annual GQMA Conference

    September 17 - September 18

Register Today!

Get Free Test Access